Typhoid Vaccine Market to Exhibit an Extraordinary Growth of USD 719.77 Million by 2029

Published August 23, 2023

Typhoid Vaccine Market

The Typhoid Vaccine market research report offers a comprehensive analysis of the market’s structure, providing estimations for various market segments and sub-segments. Serving as a valuable resource for the healthcare industry, this report defines the market, classifies its segments, outlines its applications, engagements, and tracks market trends. Additionally, it identifies and evaluates emerging trends, significant drivers, challenges, and opportunities within the market. This Typhoid Vaccine market research report also offers valuable insights into strategic actions such as mergers, expansions, acquisitions, partnerships, and investments, providing a competitive edge by offering a deep understanding of industry developments ahead of competitors.

Through meticulous efforts and integrated approaches, this report delivers an exceptional market research resource that informs the decision-making processes of businesses. It covers key aspects including market definition, currency and pricing, market segmentation, an overview of the market, premium insights, key findings, and profiles of key market players. The report meticulously analyzes the profiles of key market competitors, considering factors like company snapshot, geographical presence, product portfolio, and recent developments. For businesses seeking a competitive advantage in a rapidly evolving marketplace, choosing this Typhoid Vaccine market research report is highly recommended, as it offers numerous benefits for achieving success.

Data Bridge Market Research analyses that the Typhoid Vaccine Market was valued at USD 321.48 million in 2021 and is expected to reach USD 719.77 million by 2029, registering a CAGR of 10.6% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get a Sample Copy of The Typhoid Vaccine Market report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-typhoid-vaccine-market&Aniket

According to a study published in Lancet: Infectious Diseases, typhoid infects 21.6 million people worldwide and kills an estimated 200,000 people each year. Furthermore, economic instability in Latin America and other developing economies has resulted in poor sanitation and restricted access to clean water and food, putting people at risk of contracting typhoid. Salmonella typhi produces typhoid fever, which causes symptoms such as a high temperature, headache, loss of appetite, constipation, and nausea. Typhoid fever is primarily spread in areas with poor sanitation and contaminated water. Typhoid fever vaccines are biological formulations that provide immunity and protection against typhoid fever in humans.

Key Growth Drivers:

The surging prevalence of typhoid in various emerging economies is a major factor driving the typhoid vaccine market’s growth rate during the forecast period of 2022 to 2029. According to estimates from the International Health Metrics and Evaluation (IHME), over 12 million cases of typhoid fever were reported worldwide in 2016, resulting in around 130,000 deaths. The risk of typhoid is increased among people who do not have access to clean water and sanitation. Poor communities and vulnerable people, such as children, are particularly vulnerable.

Another significant factor influencing the growth rate of typhoid vaccine market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

The report outlines the involvement of key players, including:

  • Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Novartis AG (Switzerland)
  • Mylan N.V. (US)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Sanofi (France)
  • AstraZeneca (UK)
  • Johnson & Johnson Private Limited (US)
  • Merck & Co., Inc. (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)

Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-typhoid-vaccine-market?Aniket

Key Market Segmentation


  • Live Attenuated Vaccine
  • Monovalent Typhoid Vaccines
  • Capsular Polysaccharide Vaccines
  • Conjugate Vaccine
  • Others

Route of Administration

  • Oral
  • Parenteral


  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

The Typhoid Vaccine market report includes the following countries in different regions:

The regions mentioned above encompass a comprehensive coverage of key markets, offering a global perspective on the market landscape. Here’s an overview of the regions and the countries they include:

  1. North America: United States, Canada, and Mexico.
  2. Europe: Germany, France, United Kingdom, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and other European countries.
  3. Asia-Pacific (APAC): China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and other Asia-Pacific countries.
  4. Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates (U.A.E), South Africa, Egypt, Israel, and other countries in the Middle East and Africa region.
  5. South America: Brazil, Argentina, and other countries in South America.

Incorporating these regions into market research is crucial as they serve as significant economic and industrial hubs with diverse consumer markets. By including these regions in their analyses, businesses gain valuable insights into global trends, enabling them to make informed decisions and develop effective strategies. Understanding the market dynamics in these regions helps companies cater to the distinct demands and preferences of various regional markets, whether they plan to expand their operations or simply stay updated with the ever-changing global landscape. This approach ensures that businesses can adapt and tailor their products or services to meet the specific needs of each region, ultimately leading to a more successful and sustainable global presence.

North America dominates the typhoid vaccine market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and rising healthcare expenditure will further propel the ‘market’s growth rate in this region. Additionally, increasing patient awareness and high demand of vaccine will further propel the ‘market’s growth rate in this region.

Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to surging prevalence of typhoid diseases and favourable regulatory guidelines in this region. Also, the development of healthcare infrastructure and rising government initiatives for immunization programs will further propel the market’market’s growth rate in this region.


Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Get the Complete Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-typhoid-vaccine-market&Aniket

Browse More Reports:







About Data Bridge Market Research, Private Ltd

Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.

Contact Us

US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – 

CDN Newswire